Bjørn Erik Bergseng • 1964 • Fredrikstad • 4 roles • 12 shareholdings

This website uses cookies to enhance the user experience.

||

Roles

Management

Name	Role	Total operating income	Total equity	Shares
F FOCUS PHARMA AS	Managing Director/CEO	1,914,178	366,508	33 % directly
E ESTETISK MEDITECH AS Closed	Managing Director/CEO	89,699	1,258,655	16.5 % indirectly

Boards

Name	Role	Total operating income	Total equity	Shares
F FOCUS PHARMA AS	Board Member	1,914,178	366,508	33 % directly
E ESTETISK MEDITECH AS Closed	Board Member	89,699	1,258,655	16.5 % indirectly

Last update: Apr 13, 2023

Related industries

1

Goods and trade
Purchase and sale

Direct relationships

1

HE
Heidi Engebretsen Bergseng1969
FOCUS PHARMA AS, ESTETISK MEDITECH AS

Shares owned by Bjørn Erik Bergseng

Name	Share class	Total operating income	Total equity	Share
F FOCUS PHARMA AS	Ordinære aksjer	1,914,178	366,508	33 % directly
E ESTETISK MEDITECH AS Closed		89,699	1,258,655	16.5 % indirectly
O OBSERVE MEDICAL ASA	NO0010865009	2,935,000	12,296,000	0.06 % directly < 0.01 %
N NAVAMEDIC ASA	NO0010205966	67,348,341	0	0.04 % directly < 0.01 %
A ATLANTIC SAPPHIRE ASA	NO0013249896	13,937,000	2,072,487,000	< 0.01 % directly
H HEXAGON PURUS ASA	NO0010904923	97,033,000	590,813,000	< 0.01 % directly
V VEND MARKETPLACES ASA	NO0003028904	91,000,000	30,050,000,000	< 0.01 % directly
H HEXAGON COMPOSITES ASA	NO0003067902	101,576,000	2,520,134,000	< 0.01 % directly
M MOWI ASA	NO0003054108	1,887,000,000	2,856,000,000	< 0.01 % directly
N NYKODE THERAPEUTICS ASA	NO0010714785	453,000	94,977,000	< 0.01 % directly
T THOR MEDICAL ASA	NO0010597883	839,000	475,867,000	< 0.01 % directly
G GJENSIDIGE FORSIKRING ASA	NO0010582521	-	-	< 0.01 % directly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025